SUNZEN

0.310

+0.005 (+1.6%)

Changes in Director's Interest (Section 219 of CA 2016)

SUNZEN BIOTECH BERHAD

Information Compiled By KLSE

Particulars of Director

Name MR TEO YEK MING
Descriptions(Class) Ordinary Shares

Details of changes

No
Date of change
No of securities
Type of transaction
Nature of Interest
28/05/2021
15,466,667
Others
Direct Interest
Name of registered holder Teo Yek Ming
Description of "Others" Type of Transaction Allotment of Shares
Consideration (if any) RM0.165 per share
28/05/2021
10,909,091
Others
Indirect Interest
Name of registered holder RHB Capital Nominees (Tempatan) Sdn Bhd David Lai & Tan Services Sdn Bhd
Description of "Others" Type of Transaction Allotment of Shares
Consideration (if any) RM0.165 per share

Circumstances by reason of which change has occurred
Allotment of Consideration Shares arising from the Acquisition of Finsource Solution Sdn. Bhd. by Sunzen Biotech Berhad
Nature of interest
Direct and Indirect Interest

Total no of securities after change

Direct (units) 84,180,417
Direct (%) 14.700
Indirect/deemed interest (units) 11,035,091
Indirect/deemed interest (%) 1.930
Date of notice 31/05/2021
Date notice received by Listed Issuer 31/05/2021


Remarks :
(1) Deemed interest by virtue of 126,000 shares held by parent. (2) Deemed interest by virtue of 10,909,091 shares held as security by David Lai & Tan Services Sdn Bhd pursuant to Section 8 of the Companies Act 2016.


Announcement Info

Company Name SUNZEN BIOTECH BERHAD
Stock Name SUNZEN
Date Announced 31 May 2021
Category Changes in Director's Interest Pursuant to Section 219 of CA 2016
Reference Number CS4-15032021-00044